These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T. Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018 [Abstract] [Full Text] [Related]
43. Inhaled salmeterol/fluticasone propionate combination in chronic obstructive pulmonary disease. Lyseng-Williamson KA, Keating GM. Am J Respir Med; 2002; 1(4):273-82; discussion 283-4. PubMed ID: 14720047 [Abstract] [Full Text] [Related]
44. Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily. Busse W, Koenig SM, Oppenheimer J, Sahn SA, Yancey SW, Reilly D, Edwards LD, Dorinsky PM. J Allergy Clin Immunol; 2003 Jan; 111(1):57-65. PubMed ID: 12532097 [Abstract] [Full Text] [Related]
46. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma. Shapiro G, Lumry W, Wolfe J, Given J, White MV, Woodring A, Baitinger L, House K, Prillaman B, Shah T. Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):527-34. PubMed ID: 10673196 [Abstract] [Full Text] [Related]
47. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study. Bateman ED, van Dyk M, Sagriotis A. Pulm Pharmacol Ther; 2008 Feb; 21(1):20-5. PubMed ID: 17118684 [Abstract] [Full Text] [Related]
48. Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma. Ind PW, Dal Negro R, Colman NC, Fletcher CP, Browning D, James MH. Respir Med; 2003 May; 97(5):555-62. PubMed ID: 12735675 [Abstract] [Full Text] [Related]
49. [Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease]. Baloira Villar A, Vilariño Pombo C. Arch Bronconeumol; 2005 Mar; 41(3):130-4. PubMed ID: 15766465 [Abstract] [Full Text] [Related]
50. Acute effects of salmeterol and fluticasone propionate alone and in combination on airway blood flow in patients with asthma. Mendes ES, Rebolledo P, Wanner A. Chest; 2012 May; 141(5):1184-1189. PubMed ID: 21980058 [Abstract] [Full Text] [Related]
52. The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study). Beeh KM, Derom E, Echave-Sustaeta J, Grönke L, Hamilton A, Zhai D, Bjermer L. Int J Chron Obstruct Pulmon Dis; 2016 May; 11():193-205. PubMed ID: 26893551 [Abstract] [Full Text] [Related]
57. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD. Cazzola M, Di Perna F, Noschese P, Vinciguerra A, Calderaro F, Girbino G, Matera MG. Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576 [Abstract] [Full Text] [Related]
58. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease. Welsh EJ, Cates CJ, Poole P. Cochrane Database Syst Rev; 2010 May 12; (5):CD007891. PubMed ID: 20464758 [Abstract] [Full Text] [Related]
59. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease. Broseghini C, Testi R, Polese G, Tosatto R, Rossi A. Pulm Pharmacol Ther; 2005 May 12; 18(2):103-8. PubMed ID: 15649852 [Abstract] [Full Text] [Related]
60. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma. Reynolds NA, Lyseng-Williamson KA, Wiseman LR. Drugs; 2005 May 12; 65(12):1715-34. PubMed ID: 16060707 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]